AB186. SOH26AB_0342. Risk assessment for prostate cancer in a rapid access clinic in a level 4 Irish hospital

Prostate cancer risk stratification traditionally incorporates prostate-specific antigen (PSA), digital rectal examination (DRE), family history, and multiparametric magnetic resonance imaging (mpMRI). While mpMRI has become central to decision-making, its predictive ability when used alone in the Irish population remains unclear. This study aims to develop a prostate cancer risk calculator based solely on MRI parameters to support biopsy decisions in a Rapid Access Prostate Clinic (RAPC).